title: Response to Deng et al.'s LRRK2 patent review.
authors.forename: Daniel Jon
authors.initials: DJ
authors.lastname: Burdick
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D015195:Drug Design; D006801:Humans; D010330:Patents as Topic; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000978:Antiparkinson Agents; D047428:Protein Kinase Inhibitors; D017346:Protein Serine-Threonine Kinases